uz
Feedback
Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

Kanalga Telegram’da o‘tish

Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

Ko'proq ko'rsatish

📈 Telegram kanali Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ analitikasi

Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ (@smartlearningacademy) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 18 651 obunachidan iborat bo'lib, Taʼlim toifasida 10 717-o'rinni va Hindiston mintaqasida 22 673-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 18 651 obunachiga ega bo‘ldi.

10 Iyul, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 221 ga, so‘nggi 24 soatda esa 8 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 13.95% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 6.65% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 2 601 marta ko‘riladi; birinchi sutkada odatda 1 241 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 4 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent vedemy, nat, revision, calculation, rahe kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

Yuqori yangilanish chastotasi (oxirgi ma’lumot 11 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Taʼlim toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

18 651
Obunachilar
+824 soatlar
+397 kunlar
+22130 kunlar
Postlar arxiv
🌟 Exciting News for the Future of Medicine! 🌟 Hey Students! 🚀 Guess what? 🎉 The U.S. FDA just gave the green light to two AMAZING gene therapies, Casgevy and Lyfgenia, for treating sickle cell disease in patients aged 12 and older! 🩸💪 Casgevy is making history as the FIRST-EVER FDA-approved therapy to use CRISPR/Cas9! 🧬 This cutting-edge tech edits blood stem cells, preventing red blood cell sickling and boosting oxygen delivery. 🌬 Lyfgenia, another game-changer, uses a lentiviral vector for genetic modification, introducing HbAT87Q to mimic normal hemoglobin and reduce sickling risks! 🧬🚑 Both therapies use the patient's OWN stem cells for a one-time, single-dose infusion - talk about personalized medicine! 🩹💉 As future scientists, this is YOUR world of possibilities! 🌍✨ Stay curious, work hard, and dream BIG! 🚀 Your careers could be at the forefront of these groundbreaking innovations. 🌈 The FDA's approval of Casgevy and Lyfgenia is a high-five to the importance of scientific exploration. 🖐💡 So, keep dreaming, keep learning, and get ready to change the world! 🌟🔬 Cheers to the future of medicine and YOUR incredible journey ahead! 🎓👩‍🔬👨‍⚕️ Keep shining bright, 🌟

All PDFs of biodiversity will be available on the app by this evening

🌱✨ Quiz Alert: Unit Wise Edition ! ✨🌱 Get ready for an exciting Unit Wise quiz series , starting this Tuesday to Friday at 10 PM! 🕙🔬 📅 Tuesday: Unit 1 📅 Wednesday: Unit 2 📅 Thursday: Unit 3 📅 Friday: Unit 4

Plant hormones quiz starting in a minute

From Monday onwards, unit wise quizzes will be conducted

Plant Hormone quiz will be conducted tomorrow @10 PM

Some genuine feedbacks
Some genuine feedbacks